A proportional risk model for time-to-event analysis in randomized controlled trials

被引:4
|
作者
Kuss, Oliver [1 ]
Hoyer, Annika [2 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Leibniz Inst Diabet Res, Inst Biometr & Epidemiol, German Diabet Ctr, Dusseldorf, Germany
[2] Ludwig Maximilians Univ Munchen, Dept Stat, Munich, Germany
关键词
Risk; proportional hazard model; survival analysis; numbers needed to treat; odds ratio; MEAN SURVIVAL-TIME; CARDIOVASCULAR OUTCOMES; HAZARDS; LIFE;
D O I
10.1177/0962280220953599
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Regression models for continuous, binary, nominal, and ordinal outcomes almost completely rely on parametric models, whereas time-to-event outcomes are mainly analyzed by Cox's Proportional Hazards model, an essentially non-parametric method. This is done despite a long list of disadvantages that have been reported for the hazard ratio, and also for the odds ratio, another effect measure sometimes used for time-to-event modelling. In this paper, we propose a parametric proportional risk model for time-to-event outcomes in a two-group situation. Modelling explicitly a risk instead of a hazard or an odds solves the current interpretational and technical problems of the latter two effect measures. The model further allows for computing absolute effect measures like risk differences or numbers needed to treat. As an additional benefit, results from the model can also be communicated on the original time scale, as an accelerated or a prolongated failure time thus facilitating interpretation for a non-technical audience. Parameter estimation by maximum likelihood, while properly accounting for censoring, is straightforward and can be implemented in each statistical package that allows coding and maximizing a univariate likelihood function. We illustrate the model with an example from a randomized controlled trial on efficacy of a new glucose-lowering drug for the treatment of type 2 diabetes mellitus and give the results of a small simulation study.
引用
收藏
页码:411 / 424
页数:14
相关论文
共 50 条
  • [1] Counterfactual mediation analysis in the multistate model framework for surrogate and clinical time-to-event outcomes in randomized controlled trials
    Weir, Isabelle R.
    Rider, Jennifer R.
    Trinquart, Ludovic
    [J]. PHARMACEUTICAL STATISTICS, 2022, 21 (01) : 163 - 175
  • [2] Attributable risk function in the proportional hazards model for censored time-to-event
    Chen, Ying Qing
    Hu, Chengcheng
    Wang, Yan
    [J]. BIOSTATISTICS, 2006, 7 (04) : 515 - 529
  • [3] A nonparametric proportional risk model to assess a treatment effect in time-to-event data
    Ameis, Lucia
    Kuss, Oliver
    Hoyer, Annika
    Moellenhoff, Kathrin
    [J]. BIOMETRICAL JOURNAL, 2024, 66 (04)
  • [4] Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment
    Weir, I. R.
    Marshall, G. D.
    Schneider, J. I.
    Sherer, J. A.
    Lord, E. M.
    Gyawali, B.
    Paasche-Orlow, M. K.
    Benjamin, E. J.
    Trinquart, L.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (01) : 96 - 102
  • [5] Mixture Modeling of Time-to-Event Data in the Proportional Odds Model
    Huang, Xifen
    Xiong, Chaosong
    Xu, Jinfeng
    Shi, Jianhua
    Huang, Jinhong
    [J]. MATHEMATICS, 2022, 10 (18)
  • [6] Design and analysis of cluster randomized trials with time-to-event outcomes under the additive hazards mixed model
    Blaha, Ondrej
    Esserman, Denise
    Li, Fan
    [J]. STATISTICS IN MEDICINE, 2022, 41 (24) : 4860 - 4885
  • [7] Proportional Odds Hazard Model for Discrete Time-to-Event Data
    Vieira, Maria Gabriella Figueiredo
    Cardial, Marcilio Ramos Pereira
    Matsushita, Raul
    Nakano, Eduardo Yoshio
    [J]. AXIOMS, 2023, 12 (12)
  • [8] A proportional hazards model for time-to-event data with epidemiological bias
    Zhang, Qiaozhen
    Dai, Hongsheng
    Fu, Bo
    [J]. JOURNAL OF MULTIVARIATE ANALYSIS, 2016, 152 : 224 - 236
  • [9] Guidelines for time-to-event endpoints' definitions in cancer randomized controlled trials (RCTs) for breast cancer - results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
    Gourgou-Bourgade, S.
    Dabakuyo-Yonli, S.
    Cameron, D.
    Cardoso, F.
    Poortmans, P.
    Asselain, B.
    Azria, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S441 - S442
  • [10] Discussion on 'Correct and logical causal inference for binary and time-to-event outcomes in randomized controlled trials'
    Xi, Dong
    Bretz, Frank
    [J]. BIOMETRICAL JOURNAL, 2022, 64 (02) : 243 - 245